Literature DB >> 11272169

Overstimulation and beta-cell function.

V Grill1, A Björklund.   

Abstract

Previous and present evidence ascribes an important role to overstimulation of beta-cells for the secretory abnormalities associated with type 2 diabetes. The abnormality most clearly linked to overstimulation is the elevated ratio of circulating proinsulin to insulin. Evidence obtained in human pancreatic islets suggests that aberrations in insulin oscillations that occur in type 2 diabetes could at least in part be linked to abnormalities in cytoplasmic Ca2+ oscillations induced by overstimulation. Furthermore, in a transplantation model, we have obtained evidence for long-lasting, perhaps irreversible, effects of overstimulation, implying that this is a causative factor for the well-recognized deterioration of insulin secretion with increasing duration of type 2 diabetes. The mechanisms behind the effects of overstimulation are only partly clarified, but it is clear that reduced insulin secretion after overstimulation is only partly explained by decreased insulin stores. In cultured human pancreatic islets, overstimulation by high glucose leads to a rise in cytoplasmic Ca2+ levels, which persists after normalization of the glucose levels. Persistent elevation of cytoplasmic Ca2+ may trigger apoptosis, thus participating in long-term irreversible deterioration of beta-cell function. These data provide sufficient rationale for clinical studies to test the beneficial effects of relative beta-cell rest in type 2 diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11272169     DOI: 10.2337/diabetes.50.2007.s122

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  29 in total

1.  Do insulinotropic glucose-lowering drugs do more harm than good? The hypersecretion hypothesis revisited.

Authors:  I Rustenbeck; S Baltrusch; M Tiedge
Journal:  Diabetologia       Date:  2010-07-01       Impact factor: 10.122

2.  Evidence of diminished glucose stimulation and endoplasmic reticulum function in nonoscillatory pancreatic islets.

Authors:  Pooya Jahanshahi; Runpei Wu; Jeffrey D Carter; Craig S Nunemaker
Journal:  Endocrinology       Date:  2008-09-25       Impact factor: 4.736

3.  Reducing Glucokinase Activity Restores Endogenous Pulsatility and Enhances Insulin Secretion in Islets From db/db Mice.

Authors:  Ishrat Jahan; Kathryn L Corbin; Avery M Bogart; Nicholas B Whitticar; Christopher D Waters; Cara Schildmeyer; Nicholas W Vann; Hannah L West; Nathan C Law; Jeffrey S Wiseman; Craig S Nunemaker
Journal:  Endocrinology       Date:  2018-11-01       Impact factor: 4.736

4.  Pathologic changes and glucose homeostasis according to expression of human islet amyloid polypeptide in type 2 diabetic patients.

Authors:  Ji Young Park; Hee Sung No; You Ran Ahn; Seung Hoon Oh; Young Seok Kim; Sook Young Kim; Kee Taek Jang; Sun Wook Kim; Jae Hoon Chung; Yong Ki Min; Jin Seok Heo; Seong Ho Choi; Dong Wook Choi; Myung-Shik Lee; Moon Kyu Lee; Jae Hyeon Kim; Kwang-Won Kim
Journal:  J Histochem Cytochem       Date:  2010-04-26       Impact factor: 2.479

5.  Openers of ATP-dependent K+-channels protect against a signal-transduction-linked and not freely reversible defect of insulin secretion in a rat islet transplantation model of Type 2 diabetes.

Authors:  A Björklund; J Bondo Hansen; S Falkmer; V Grill
Journal:  Diabetologia       Date:  2004-04-16       Impact factor: 10.122

6.  Liraglutide in the treatment of type 2 diabetes mellitus: clinical utility and patient perspectives.

Authors:  Mahamood Edavalath; Jeffrey W Stephens
Journal:  Patient Prefer Adherence       Date:  2010-03-24       Impact factor: 2.711

Review 7.  Hyperinsulinism and diabetes: genetic dissection of beta cell metabolism-excitation coupling in mice.

Authors:  Maria Sara Remedi; Colin G Nichols
Journal:  Cell Metab       Date:  2009-12       Impact factor: 27.287

8.  Dietary glycemic index, development of islet autoimmunity, and subsequent progression to type 1 diabetes in young children.

Authors:  Molly M Lamb; Xiang Yin; Katherine Barriga; Michelle R Hoffman; Anna E Barón; George S Eisenbarth; Marian Rewers; Jill M Norris
Journal:  J Clin Endocrinol Metab       Date:  2008-08-05       Impact factor: 5.958

Review 9.  Anti-CD38 autoantibodies in type? diabetes.

Authors:  Roberto Mallone; Paolo Cavallo Perin
Journal:  Diabetes Metab Res Rev       Date:  2006 Jul-Aug       Impact factor: 4.876

Review 10.  Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications.

Authors:  M Y Donath; P A Halban
Journal:  Diabetologia       Date:  2004-02-07       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.